Related Experiment Video

Updated: Aug 23, 2026

Chinese Herbal Retention Enema for the Treatment of Ulcerative Colitis
06:19

Chinese Herbal Retention Enema for the Treatment of Ulcerative Colitis

Published on: May 16, 2025

Guidelines for treatment of ulcerative colitis in children

Takeshi Tomomasa1, Akio Kobayashi, Kousuke Ushijima

  • 1Department of Pediatrics, Gunma University Graduate School, Japan. tomomasa@showa.gunma-u.ac.jp

Pediatrics International : Official Journal of the Japan Pediatric Society
|August 18, 2004
PubMed

Insights

This paper outlines new guidelines for treating pediatric ulcerative colitis, emphasizing intensive early treatment and cautious steroid use to prevent growth issues. Severe cases may benefit from advanced therapies like pulsed steroids and cyclosporin.

Area of Science:

  • Pediatric Gastroenterology
  • Pediatric Inflammatory Bowel Disease (IBD)

Background:

  • Ulcerative colitis (UC) treatment in children requires specific considerations distinct from adult protocols.
  • Growth disturbances are a significant concern with prolonged corticosteroid use in pediatric patients.

Framework:

  • Guidelines developed by the Japanese Society for Pediatric Gastroenterology, Hepatology and Nutrition and the Japanese Society for Pediatric Inflammatory Bowel Disease (IBD).
  • Focus on fundamental differences in medical treatment between pediatric and adult patients.

Implementation:

  • Emphasizes intensive medical treatment and systemic management during the acute phase of pediatric ulcerative colitis.
  • Recommends against prolonged corticosteroid therapy due to potential growth disturbances.
  • Includes pulsed steroid therapy, selective plasmafiltration, and intravenous cyclosporin as therapeutic options for severe and fulminant cases.

Implications:

  • Provides a framework for optimizing ulcerative colitis management in children.
  • Aims to improve treatment outcomes while minimizing long-term side effects like growth impairment.
  • Highlights the importance of tailored therapeutic strategies for pediatric IBD.

Related Concept Videos

Drugs for Treatment of Ulcerative Colitis in IBD01:29

Drugs for Treatment of Ulcerative Colitis in IBD

Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide generation. 
Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids01:21

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2 (COX-2),...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...